Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus

Trial Profile

Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 12 Nov 2017

At a glance

  • Drugs AI 401 (Primary)
  • Indications Type 1 diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 12 Nov 2017 Primary endpoint (Time to diabetes in the main study group) has not been met, according to results published in the JAMA: the Journal of the American Medical Association.
    • 12 Nov 2017 Results (database lock up date: 20 Jan 2017) of this trial alongwith post hoc analysis and preplanned exploratory analysis results, published in the JAMA: the Journal of the American Medical Association.
    • 10 Jun 2017 Biomarkers information updated
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top